We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanot... Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Show more
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their...
-- First quarter 2024 net revenue from global sales of IMCIVREEยฎ (setmelanotide) of $26.0 million -- -- On track to submit sNDA to the FDA to treat pediatric patients between 2 and younger than 6...
-- Oral presentation showcased previously disclosed data that demonstrate setmelanotide achieved 3.04 mean reduction in BMI-Z score and 18.4 percent mean reduction in BMI in 12 patients ages...
- Publication highlights administration of setmelanotide therapy resulted in a mean percent reduction in BMI of 15% at 16 weeks and 26% at one year of treatment - - Topline data from ongoing...
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their...
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.35 | 3.52941176471 | 38.25 | 41.89 | 36.58 | 544350 | 39.22158876 | CS |
4 | 0.5 | 1.27877237852 | 39.1 | 44.37 | 36.58 | 591314 | 40.08110101 | CS |
12 | -8.94 | -18.4177997528 | 48.54 | 49.5307 | 36.58 | 580770 | 41.09946338 | CS |
26 | 7 | 21.472392638 | 32.6 | 52.57 | 30.9 | 669905 | 41.94858246 | CS |
52 | 23.09 | 139.854633555 | 16.51 | 52.57 | 15.5001 | 678196 | 31.53500512 | CS |
156 | 17.34 | 77.897574124 | 22.26 | 52.57 | 3.04 | 763505 | 20.22633087 | CS |
260 | 13.99 | 54.6270987895 | 25.61 | 52.57 | 3.04 | 573674 | 20.96765378 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions